Stock RASP ACTAVIA LIFE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Actavia Life Sciences, Inc.

Equities

RASP

US7538881068

Market Closed - OTC Markets
Other stock markets
 09:59:02 16/05/2024 pm IST 		5-day change 1st Jan Change
0.0169 USD +17.36% Intraday chart for Actavia Life Sciences, Inc. -.--% +119.48%
20/05 Actavia Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
16/02 Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Actavia Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CI
Actavia Life Sciences : Change in Certifying Accountants - Form 8-K
PU
Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
Actavia Life Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
CI
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
CI
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
CI
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022
CI
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022
CI
Rasna Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
CI
Rasna Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K
PU
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
CI
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022
CI
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RASP Stock
  4. News Actavia Life Sciences, Inc.